| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
936 |
911 |
$230K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
591 |
577 |
$45K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
407 |
404 |
$38K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
257 |
257 |
$33K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
761 |
437 |
$29K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
660 |
658 |
$20K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
98 |
98 |
$13K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
67 |
57 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
55 |
55 |
$8K |
| 96127 |
|
348 |
348 |
$6K |
| 90461 |
|
271 |
92 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
71 |
71 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
120 |
120 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
128 |
128 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
105 |
105 |
$2K |
| 99188 |
|
13 |
13 |
$929.50 |
| 87081 |
|
84 |
83 |
$748.01 |
| 87807 |
|
13 |
13 |
$226.72 |